Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: A molybdenum oxide-based degradable nanosheet for combined chemo-photothermal therapy to improve tumor immunosuppression and suppress distant tumors and lung metastases

Fig. 5

A Blood analysis of mice on day 15 post-injection of FA-BSA-PEG/MoOx nanosheets (20 mg/kg) or saline from the tail vein. Detection indicators: AST, ALT, BUN and CR; B the body weight change curve of mice after intravenous administration of FA-BSA-PEG/MoOx nanosheets (20 mg/kg) or saline for 15 days; C H&E stained images of main organs retrieved form mice treated by normal saline and FA-BSA-PEG/MoOx nanosheet; D plasma DTX concentration–time curve for intravenous administration of commercial Taxotere® and nanosheet in rats (n = 3)

Back to article page